Continuing Education Activity

Cri du Chat syndrome is a rare chromosomal deletion disorder caused by partial or complete loss of the short arm of chromosome 5, producing a characteristic high-pitched cat-like cry in infancy along with craniofacial abnormalities, developmental delay, intellectual disability, and multisystem complications. This course reviews the clinical features of this disorder, which can vary in severity according to the size and location of the deletion, reflecting important genotype–phenotype correlations that influence neurologic, behavioral, cardiovascular, feeding, and developmental manifestations. Advances in prenatal screening, cytogenetics, chromosomal microarray analysis, and fluorescence in situ hybridization are also discussed. Patients will also gain an understanding of management approaches that remain supportive and interprofessional, emphasizing early intervention, rehabilitation therapies, developmental support, medical surveillance, and genetic counseling. This activity for healthcare professionals is designed to enhance the learner's competence in identifying the genetic basis and clinical presentation of Cri du Chat syndrome, applying an appropriate diagnostic evaluation, understanding associated comorbidities, and implementing an appropriate interprofessional approach when managing this condition to optimize long-term outcomes, coordinate interprofessional care, and improve quality of life for affected individuals and their families.

Objectives:

• Identify the characteristic clinical features of Cri du Chat syndrome to facilitate early recognition.
• Apply the appropriate diagnostic evaluation for Cri du Chat syndrome.
• Implement evidence-based management strategies for Cri du Chat syndrome.
• Collaborate effectively within an interprofessional team to improve care coordination and outcomes in patients with Cri du Chat syndrome.

Access free multiple choice questions on this topic.

Introduction

Cri du Chat syndrome represents a genetic disorder caused by the deletion of the short arm of chromosome 5. The syndrome’s name, meaning “cat cry,” derives from the characteristic high-pitched, monochromatic, cat-like cry frequently observed during infancy. Clinical presentation and disease severity vary according to the size, location, and type of chromosomal deletion, whether terminal or interstitial, reflecting well-established genotype–phenotype correlations. Phenotypic variability directly corresponds to underlying genotypic differences. Common clinical features include distinctive craniofacial abnormalities, developmental delay, and intellectual disability.[1][2]

Beyond the core developmental manifestations, affected individuals may also demonstrate behavioral and neurodevelopmental abnormalities. Findings from one study showed that children with higher levels of fatigue more commonly exhibited increased autistic traits or symptoms.[3]

Etiology

Cri du Chat results from either a partial or complete deletion of the short arm of chromosome 5. Most deletions occur de novo. Deletions usually arise as spontaneous chromosomal events during gametogenesis or early embryogenesis. Around 80% to 90% are paternal in origin, which can arise from chromosomal breakage during gamete formation. The remaining 10% to 15% result from unbalanced parental translocation. Moreover, 80% to 90% of cases result from terminal deletions of chromosome 5, while 3% to 5% result from interstitial deletions. Mosaicism, inversions, and ring chromosomes are less common mechanisms.[2]

Epidemiology

Although Cri du Chat is considered rare, this syndrome is one of the most common chromosomal anomalies. The incidence ranges from 1 in 15,000 to 1 in 50,000 liveborn infants. The incidence in females is slightly higher than in males. The exact worldwide incidence and prevalence, and those among races, have not been established. Similarly, specific risk factors associated with prenatal events or parental age are unclear. However, occasional reports of parental exposure to radiation, hyperemesis, anorexia, and toxemia are documented.[4]

Pathophysiology

Patients demonstrate phenotypic and genotypic variability. Research has revealed that partial deletion of the short arm of chromosome 5 causes the characteristic phenotype. The phenotype is identifiable despite variations in deletion size, leading to the theory that a critical region is responsible for the characteristic feature in hemizygosity. The region identified is 5p15.2, and individuals with a deletion of chromosome 5 that does not include this region do not show a typical phenotype and, in some cases, are even normal.

Cytogenetic studies have identified 2 regions: 5p15.3, responsible for the characteristic cry, and 5p15.2, responsible for other significant clinical findings, eg, developmental and craniofacial manifestations. Similarly, other areas have been identified for additional features, eg, speech retardation and dysmorphism. Therefore, clinical manifestations depend on the deletion of the critical area. Another crucial factor in the manifestation is the size, type of deletion, and whether it is interstitial or terminal. The most characteristic feature of this disease is high-pitched crying, and the pathogenesis is attributable to the anatomical alteration of the laryngeal morphology, which may be a result of the following:

• A small, floppy epiglottis
• Hypoplasia of the larynx
• A narrow or diamond-shaped larynx
• Abnormal airspace in the posterior area during phonation

However, not all patients with abnormal crying have the above features. Therefore, there may be neurological changes as well.[4][5]

History and Physical

Neonatal Period

In the neonatal period, the most characteristic finding is a high-pitched, monotonous cry, which usually disappears within the first few months of life. The cry is not limited to this syndrome and is also seen in a few other neurological disorders. Newborns also exhibit low birthweight and microcephaly, as well as asphyxia, muscle hypotonia, and impaired suction. These lead to impaired growth and development during the first few years of life. Reports of recurrent respiratory and intestinal infections exist.[4]

General Characteristics of Cri Du Chat Syndrome

Craniofacial malformations

Characteristic craniofacial malformations include:

• Microcephaly
• Moon face
• Hypertelorism
• Prominent epicanthic folds
• Large nasal bridge
• Downturned corners of the mouth
• Short philtrum
• Premature gray hair
• Abnormal transverse flexion creases

 Uncommonly seen clinical features include:

• Downward slanting palpebral fissures
• Low-set ears
• Narrow auditory ducts
• Preauricular tags
• Deafness
• Myopia and cataracts
• Hypersensitivity of pupils to methacholine
• Hypospadias and cryptorchidism

With increasing age, the following features change:

• Hypotonia in the neonatal period is replaced with hypertonia
• Prominent microcephaly
• Prominent supraorbital arch
• Dental malocclusions
• Moon face changes into a more narrow vertical face in adulthood

Other anomalies

Other anomalies that may also be present include:

• Hypersensitivity to sound
• Cardiac disorders, including congenital heart defects
• Cutaneous hemangioma
• Renal pathology

Orofacial abnormalities

Characteristic orofacial abnormalities include:

• High palate
• Mandibular microretrognathia
• Hypoplasia of the enamel
• Chronic periodontitis

Developmental and behavioral manifestations

Common developmental and behavioral manifestations that may be present include:

• Hyperactivity
• Self-injurious behavior
• Repetitive movements
• Gentle personality
• Obsessive attachment to objects
• Comprehension of speech is better than their ability to express or communicate [2]

Evaluation

Prenatal Screening and Diagnostic Evaluation

As most cases occur de novo in the absence of specific risk factors, prenatal diagnosis is often limited. Nevertheless, advances in prenatal genetic testing have improved opportunities for earlier detection.

Noninvasive testing

Expanded cell-free DNA screening (noninvasive prenatal testing, NIPT) may detect selected chromosomal copy-number abnormalities, including 5p deletions associated with Cri du Chat syndrome. Sensitivity and positive predictive value vary across studies and population prevalence; still, 2 studies have reported a positive predictive value of 50% for Cri du Chat. Therefore, positive screening results require confirmatory invasive testing.

Conversely, a negative test may yield a more definitive result, with a negative predictive value of 100% reported. In any case, this figure may vary depending on the specific population's genetic pool. In addition to conventional cytogenetics and comparative genomic hybridization, analysis of fetal DNA in maternal blood is a recent method for identifying deletions.

Ultrasound imaging

Studies report that structural abnormalities may be seen on anatomical scans, often involving multiple systems. At least 1 abnormal finding has been reported in around 87% of cases, while 13% show no abnormal features. The most common ultrasound findings noted are cerebellar hypoplasia, cardiac abnormalities (commonly ventricular septal defects), hydrops fetalis, ventriculomegaly, chorioid plexus cyst, and nasal bone hypoplasia. An increase in the nuchal translucency is also seen. A combination of these features should warrant chromosomal studies. Additionally, fetuses who show mosaicism may display fetoplacental and feto-amniotic chromosomal abnormalities along with microcephaly and cerebellar hypoplasia.

Invasive testing

Cri du chat is diagnosable via amniocentesis during the antenatal period, in which a deletion of chromosome 5 is visible. In addition to conventional cytogenetics, chromosomal microarray analysis is widely used because it more precisely defines deletion size and breakpoint regions and detects additional copy-number abnormalities. FISH or conventional cytogenetics identifies parental chromosomal abnormalities in approximately 10% of cases.[4][6][7][8][9][10][11]

Postnatal Diagnostic Evaluation

A diagnosis can be made based on clinical findings. The combined presence of specific characteristic findings, eg, microcephaly, low birth weight, moon facies, muscle hypotonia, and a cat-like cry, should raise clinical suspicion for the condition. Sometimes, this can be difficult because the features may not be obvious, as patients exhibit cytogenetic variation that leads to phenotypic variation. The size and position of the deletion can determine the clinical features, severity, and prognosis.

If clinical suspicion is present, a karyotype analysis is one of the first tests to confirm the diagnosis. However, in cases with high clinical suspicion but a normal karyotype, additional specific tests can be performed, eg, fluorescence in situ hybridization (FISH), comparative genomic hybridization, or quantitative polymerase chain reaction (PCR). FISH has improved the diagnosis of genetic disorders caused by chromosome deletions and provides a genotype–phenotype map by analyzing each affected individual’s genome.

Newer techniques, eg, comparative genomic hybridization, have opened new doors by enabling analysis of the whole genome and associated markers to identify genetic alterations. Very few studies have examined MRI findings; however, pontine hypoplasia appears to be the most common feature. This presentation is associated with other findings, eg, cerebellar hypoplasia, microcephaly, and corpus callosum anomalies. Supratentorial abnormalities have also been observed.[2][12]

Treatment / Management

Cri du Chat syndrome has no disease-specific curative therapy; management is supportive, interprofessional, and tailored to the individual's clinical manifestations. Early intervention is strongly recommended, as timely rehabilitation has been associated with improved developmental progress, functional ability, and social adaptation.[7]

Neonatal and Infant Care

During the neonatal period, assessment for feeding difficulties, poor suck, impaired swallowing, and hypotonia is important. Infants may benefit from early physiotherapy and speech-language input to support feeding, while intensive neonatal care is only occasionally required. Breastfeeding may still be possible with appropriate support.[7][13][1][14]

Rehabilitation and Developmental Support

Ongoing rehabilitation commonly includes physiotherapy, occupational therapy, psychomotor therapy, and speech and language therapy to address motor delay, communication difficulties, and functional independence. Because expressive language impairment may be significant, augmentative and alternative communication methods, eg, gesture systems, sign-supported communication, or visual aids, should be considered when appropriate to improve nonverbal communication.[7][15] 

Speech and language therapy has been shown to improve speech clarity and articulation in children with Cri du Chat.[15] The reported benefits of physiotherapy include earlier or more reliable achievement of motor developmental milestones, improved postural control and gait stability, and better social participation and performance of activities of daily living; however, most of this evidence comes from case reports or small cohorts, which limits the strength of recommendations.[16][4][17]

Medical Surveillance and Associated Conditions

Regular surveillance for associated comorbidities is advised. Audiological assessment should be undertaken in all children because sensorineural hearing loss may occur. Additional review may include ophthalmology, cardiology, orthopedics, dental care, and nutritional assessment, depending on symptoms. Surgical intervention may be required for congenital cardiac defects, strabismus, scoliosis, or other correctable anomalies.[7]

Behavioral and Psychological Support

Behavioral and psychological support may be beneficial for patients with hyperactivity, anxiety, sleep disturbance, or repetitive behaviors. Educational support, including individualized learning plans and structured environments, can help maximize developmental potential.[7]

Family Support and Genetic Counseling

Families should be actively involved in care planning and offered information regarding the condition, available community resources, and patient support organizations. Genetic counseling is recommended, particularly when a parental chromosomal rearrangement is suspected or for future pregnancy planning.[7][4][18]

Differential Diagnosis

The differential diagnosis of Cri du Chat syndrome includes the following:

• Wolf-Hirschhorn syndrome: A close chromosomal mimic, as Wolf-Hirschhorn syndrome is caused by the deletion of the short arm of chromosome 4. This condition overlaps with features seen in Cri du Chat, including growth delay, hypotonia, feeding issues, microcephaly, and distinctive facial dysmorphisms.[19]

• 1p36 deletion syndrome: This disorder should be considered a differential when features, eg, hypotonia, facial dysmorphism, severe developmental delay, and microcephaly are present. This syndrome is characterized by deep-set eyes, hearing loss, straight eyebrows, and structural brain abnormalities.[20]

• Distal 9p deletion syndrome/monosomy 9p: This disorder has overlapping features with Cri du Chat syndrome, namely microcephaly, hypotonia, intellectual delay; however, distal 9p deletion syndrome/monosomy 9p can be distinguished from Cri du Chat syndrome by the presence of a long philtrum, trigonocephaly, and higher incidences of genital anomalies.[21]

• Cornelia de Lange syndrome (CdLs): This syndrome has features similar to Cri du Chat, including microcephaly, feeding difficulties, facial dysmorphism, and severe speech and developmental impairment; however, unlike Cri du Chat, CdLs can be distinguished by hypertrichosis, digital anomalies, or upper limb reduction defects, and severe reflux.[22]

• Bohring-Opitz syndrome: This syndrome is rare but can mimic Cri du Chat as they present with microcephaly, feeding difficulties, and severe developmental delay. However, characteristic features of flexed elbows and wrists with ulnar deviation, recurrent vomiting, facial naevus, and early infections are noted, which are inconsistent with the diagnosis of Cri du Chat.[23]

• Smith-Lemli-Opitz syndrome: This disorder is an important metabolic/genetic exclusion as it overlaps with growth restriction, microcephaly, moderate-to-severe intellectual disability, hypotonia, and facial dysmorphism. Smith-Lemli-Opitz syndrome is characterized by 2- to 3-toe syndactyly, postaxial polydactyly, genital anomalies in males, and abnormal sterol biochemistry.[24]

Prognosis

Morbidity and mortality rates tend to decrease after the first few years of life. Historically, studies report that 75% of deaths occur during the first month of life, and about 90% of deaths occur during the first year. Notably, the type, size, and location of the deletions significantly influence the prognosis. An early diagnosis is one of the most important factors in the prognosis of the disease. Early diagnosis enables the implementation of therapeutic measures to improve physical and psychomotor development outcomes and support social adaptation.[2]

Complications

Individuals with Cri du Chat may experience multisystem complications that vary depending on the size and location of the deletion. Early recognition and interprofessional intervention can reduce functional complications and improve quality of life. Complications can include:

• Neurodevelopmental: Hypotonia in infancy can contribute to delayed motor milestones.
• Growth and feeding: Failure to thrive, poor weight gain, and dehydration can result from feeding difficulties secondary to hypotonia and poor suck/swallow functions.
• Infections: Recurrent respiratory infections can result from hypotonia, ineffective airway clearance, and structural abnormalities. These remain an important cause for morbidity in infancy.
• Cardiovascular: Congenital abnormalities, eg, ventricular septal defects, may increase morbidity and mortality if not identified early.
• Musculoskeletal: Hypotonia can affect mobility, gait, and posture. 

Mortality is highest in early childhood and is usually associated with severe congenital malformations, particularly cardiac disease, or serious respiratory complications. Many individuals survive into adulthood with appropriate supportive care.[2]

Deterrence and Patient Education

Although Cri du Chat syndrome is not preventable in most de novo cases, family education and psychosocial support are essential aspects of management. Families frequently experience increased stress, particularly when affected children display maladaptive or behavioral difficulties. Social support networks and professional guidance can reduce caregiver burden and improve coping strategies. Genetic counseling is recommended to explain recurrence risk, chromosomal mechanisms, and reproductive options. Families should also be provided with current information on developmental expectations, therapeutic interventions, educational planning, and available support organizations.[25][4][1]

Pearls and Other Issues

Key facts about Cri du Chat include the following:

• Cri du Chat syndrome is a rare genetic disorder caused by a partial or complete deletion of the short arm of chromosome 5.
• Clinical features vary according to the size and location of the deletion, with genotype influencing phenotype, developmental outcomes, and overall prognosis.
• The classic hallmark is a high-pitched, monotonic "cat-like" cry in infancy. Other common features include microcephaly, low birth weight, hypotonia, developmental delay, intellectual disability, psychomotor impairment, and characteristic craniofacial abnormalities.
• Diagnosis may be suspected clinically based on characteristic physical and developmental features. Confirmation is typically made with chromosomal analysis.
• If conventional karyotyping is normal but clinical suspicion remains high, more sensitive cytogenetic or molecular techniques such as fluorescence in situ hybridization, chromosomal microarray/comparative genomic hybridization, or other genomic testing may be required.
• Management is supportive and interprofessional, with emphasis on early intervention, including physiotherapy, occupational therapy, speech and language therapy, educational support, and family counseling, all of which can improve functional outcomes and social adaptation.
• Morbidity and mortality are greatest in early life, particularly during infancy, with most reported deaths occurring within the first year, often related to associated congenital anomalies or medical complications.

Enhancing Healthcare Team Outcomes

Cri du Chat syndrome is a chromosomal deletion disorder caused by partial or complete deletion of the short arm of chromosome 5, most commonly involving the critical regions 5p15.2 and 5p15.3. The condition classically presents with a high-pitched cat-like cry in infancy, microcephaly, hypotonia, developmental delay, intellectual disability, craniofacial abnormalities, feeding difficulties, and behavioral manifestations. Clinical severity varies according to deletion size and location, resulting in significant genotype–phenotype variability. Diagnosis relies on clinical suspicion supported by cytogenetic testing, chromosomal microarray analysis, fluorescence in situ hybridization, or prenatal testing modalities. Management remains supportive and focuses on early intervention, rehabilitation therapies, developmental support, surveillance for associated cardiac, auditory, ophthalmologic, musculoskeletal, and nutritional complications, and genetic counseling. Early recognition and coordinated care improve functional outcomes, communication skills, and quality of life while reducing morbidity related to feeding difficulties, infections, and congenital anomalies.

Interprofessional collaboration plays a central role in optimizing patient-centered outcomes and reducing preventable complications in individuals with Cri du Chat syndrome. Physicians, primary care clinicians, geneticists, advanced practitioners, nurses, speech-language pathologists, physical and occupational therapists, psychologists, dietitians, social workers, and pharmacists coordinate longitudinal care through shared decision-making and regular communication with families. Clinicians facilitate timely referral for developmental therapies, cardiac evaluation, audiology, ophthalmology, and behavioral support while monitoring growth, nutrition, mobility, and developmental progress. Nurses reinforce caregiver education, monitor feeding and respiratory status, and support care coordination across settings. Pharmacists assist with medication review and adverse-effect monitoring when behavioral or comorbid conditions require pharmacotherapy. Structured follow-up, individualized educational planning, and coordinated rehabilitation strategies strengthen systems-based practice, improve safety, and support long-term developmental and psychosocial outcomes.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Espirito Santo LD, Moreira LM, Riegel M. Cri-Du-Chat Syndrome: Clinical Profile and Chromosomal Microarray Analysis in Six Patients. Biomed Res Int. 2016;2016:5467083. [PMC free article: PMC4838791] [PubMed: 27144168]

2.

Rodríguez-Caballero A, Torres-Lagares D, Rodríguez-Pérez A, Serrera-Figallo MA, Hernández-Guisado JM, Machuca-Portillo G. Cri du chat syndrome: a critical review. Med Oral Patol Oral Cir Bucal. 2010 May 01;15(3):e473-8. [PubMed: 20038906]

3.

Claro A, Cornish K, Gruber R. Association between fatigue and autistic symptoms in children with cri du chat syndrome. Am J Intellect Dev Disabil. 2011 Jul;116(4):278-89. [PubMed: 21740256]

4.

Cerruti Mainardi P. Cri du Chat syndrome. Orphanet J Rare Dis. 2006 Sep 05;1:33. [PMC free article: PMC1574300] [PubMed: 16953888]

5.

Gersh M, Goodart SA, Pasztor LM, Harris DJ, Weiss L, Overhauser J. Evidence for a distinct region causing a cat-like cry in patients with 5p deletions. Am J Hum Genet. 1995 Jun;56(6):1404-10. [PMC free article: PMC1801088] [PubMed: 7762563]

6.

Corrêa T, Feltes BC, Riegel M. Integrated analysis of the critical region 5p15.3-p15.2 associated with cri-du-chat syndrome. Genet Mol Biol. 2019;42(1 suppl 1):186-196. [PMC free article: PMC6687350] [PubMed: 30985858]

7.

Liverani ME, Spano A, Danesino C, Malacarne M, Cavani S, Spunton M, Guala A. Children and adults affected by Cri du Chat syndrome: Care's recommendations. Pediatr Rep. 2019 Feb 26;11(1):7839. [PMC free article: PMC6397997] [PubMed: 30838120]

8.

Vado Y, Errea-Dorronsoro J, Llano-Rivas I, Gorria N, Pereda A, Gener B, Garcia-Naveda L, Perez de Nanclares G. Cri-du-chat syndrome mimics Silver-Russell syndrome depending on the size of the deletion: a case report. BMC Med Genomics. 2018 Dec 27;11(1):124. [PMC free article: PMC6307281] [PubMed: 30587166]

9.

Xue H, Yu A, Lin M, Chen X, Guo Q, Xu L, Huang H. Efficiency of expanded noninvasive prenatal testing in the detection of fetal subchromosomal microdeletion and microduplication in a cohort of 31,256 single pregnancies. Sci Rep. 2022 Nov 17;12(1):19750. [PMC free article: PMC9672043] [PubMed: 36396840]

10.

Liang D, Cram DS, Tan H, Linpeng S, Liu Y, Sun H, Zhang Y, Tian F, Zhu H, Xu M, Wang H, Yu F, Wu L. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med. 2019 Sep;21(9):1998-2006. [PubMed: 30828085]

11.

Traisrisilp K, Yanase Y, Ake-Sittipaisarn S, Tongsong T. Prenatal Sonographic Features of Cri-du-Chat Syndrome: A Case Report and Analytical Literature Review. Diagnostics (Basel). 2022 Feb 06;12(2) [PMC free article: PMC8871365] [PubMed: 35204510]

12.

Méndez-Rosado LA, García D, Molina-Gamboa O, García A, de León N, Lantigua-Cruz A, Liehr T. Algorithm for the diagnosis of patients with neurodevelopmental disorders and suspicion of a genetic syndrome. Arch Argent Pediatr. 2020 Feb;118(1):52-55. [PubMed: 31984699]

13.

Huisman S, Mulder P, Kuijk J, Kerstholt M, van Eeghen A, Leenders A, van Balkom I, Oliver C, Piening S, Hennekam R. Self-injurious behavior. Neurosci Biobehav Rev. 2018 Jan;84:483-491. [PubMed: 28694012]

14.

Corcuera-Flores JR, Casttellanos-Cosano L, Torres-Lagares D, Serrera-Figallo MÁ, Rodríguez-Caballero Á, Machuca-Portillo G. A systematic review of the oral and craniofacial manifestations of cri du chat syndrome. Clin Anat. 2016 Jul;29(5):555-60. [PubMed: 26457586]

15.

Papadopoulou S, Anagnostopoulou A, Katsarou DV, Megari K, Efthymiou E, Argyriadis A, Kougioumtzis G, Theodoratou M, Sofologi M, Argyriadi A, Pavlidou E, Toki EI. Enhancing Communication and Swallowing Skills in Children with Cri Du Chat Syndrome: A Comprehensive Speech Therapy Guide. Children (Basel). 2024 Dec 16;11(12) [PMC free article: PMC11727555] [PubMed: 39767955]

16.

Yardımcı-Lokmanoğlu BN, Mutlu A, Livanelioğlu A, Haliloğlu G. The general movements assessment and effects of an early intervention in an infant with Cri du chat syndrome: a case report. Turk J Pediatr. 2021;63(1):167-173. [PubMed: 33686841]

17.

Mainardi PC, Pastore G, Castronovo C, Godi M, Guala A, Tamiazzo S, Provera S, Pierluigi M, Bricarelli FD. The natural history of Cri du Chat Syndrome. A report from the Italian Register. Eur J Med Genet. 2006 Sep-Oct;49(5):363-83. [PubMed: 16473053]

18.

Nguyen JM, Qualmann KJ, Okashah R, Reilly A, Alexeyev MF, Campbell DJ. 5p deletions: Current knowledge and future directions. Am J Med Genet C Semin Med Genet. 2015 Sep;169(3):224-38. [PMC free article: PMC4736720] [PubMed: 26235846]

19.

Popescu DE, Marian D, Zeleniuc M, Samoila C, Belengeanu V. Features of the Wolf-Hirschhorn Syndrome (WHS) from Infant to Young Teenager. Balkan J Med Genet. 2023 Jul;26(1):75-82. [PMC free article: PMC10413881] [PubMed: 37576793]

20.

Jacquin C, Landais E, Poirsier C, Afenjar A, Akhavi A, Bednarek N, Bénech C, Bonnard A, Bosquet D, Burglen L, Callier P, Chantot-Bastaraud S, Coubes C, Coutton C, Delobel B, Descharmes M, Dupont JM, Gatinois V, Gruchy N, Guterman S, Heddar A, Herissant L, Heron D, Isidor B, Jaeger P, Jouret G, Keren B, Kuentz P, Le Caignec C, Levy J, Lopez N, Manssens Z, Martin-Coignard D, Marey I, Mignot C, Missirian C, Pebrel-Richard C, Pinson L, Puechberty J, Redon S, Sanlaville D, Spodenkiewicz M, Tabet AC, Verloes A, Vieville G, Yardin C, Vialard F, Doco-Fenzy M. 1p36 deletion syndrome: Review and mapping with further characterization of the phenotype, a new cohort of 86 patients. Am J Med Genet A. 2023 Feb;191(2):445-458. [PMC free article: PMC10100125] [PubMed: 36369750]

21.

Hauge X, Raca G, Cooper S, May K, Spiro R, Adam M, Martin CL. Detailed characterization of, and clinical correlations in, 10 patients with distal deletions of chromosome 9p. Genet Med. 2008 Aug;10(8):599-611. [PMC free article: PMC2953383] [PubMed: 18641517]

22.

Deardorff MA, Raible SE, Krantz ID. Cornelia de Lange Syndrome. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews^® [Internet]. University of Washington, Seattle; Seattle (WA): Sep 16, 2005. [PubMed: 20301283]

23.

Russell BE, Johnson A, Tan WH. ASXL1-Related Bohring-Opitz Syndrome. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews^® [Internet]. University of Washington, Seattle; Seattle (WA): Feb 15, 2018. [PubMed: 29446906]

24.

Nowaczyk MJM, Wassif CA. Smith-Lemli-Opitz Syndrome. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews^® [Internet]. University of Washington, Seattle; Seattle (WA): Nov 13, 1998. [PubMed: 20301322]

25.

Hodapp RM, Wijma CA, Masino LL. Families of children with 5p- (cri du chat) syndrome: familial stress and sibling reactions. Dev Med Child Neurol. 1997 Nov;39(11):757-61. [PubMed: 9393890]

Disclosure: Anitha Ajitkumar declares no relevant financial relationships with ineligible companies.

Disclosure: Manan Shah declares no relevant financial relationships with ineligible companies.